Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma

A. P. Barbour, E. T. Walpole, G. T. Mai, L. Barnes, D. I. Watson, S. P. Ackland, V. Wills, J. Martin, M. Burge, C. S. Karapetis, J. Shannon, L. M. Nott, V. Gebski, M. Oostendorp, K. Wilson, J. Thomas, G. Lampe, J. R. Zalcberg, J. Simes, M. Smithers

    Research output: Contribution to journalArticle

    Fingerprint Dive into the research topics of 'Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma'. Together they form a unique fingerprint.

    Medicine & Life Sciences